RAPPAHANNOCK GENERAL HOSPITAL — History
CCN 491308 | 3-year financial timeline | COVID resilience: 50/100
🛡️ Public data only — no PHI permitted on this instance.
$42M
Latest Revenue (FY2022)
+7.8%
Revenue CAGR (3yr)
-17.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $36M | $39M | $42M | +7.7% | +7.8% |
| Operating Expenses | $41M | $45M | $50M | +9.6% | +10.8% |
| Operating Margin | -11.7% | -15.9% | -17.9% | -12.9% | +0.0% |
| Net Income | $-4M | $-6M | $-8M | -21.5% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 2,761 | 2,760 | 2,515 | -8.9% | -4.6% |
| Medicare Day % | 67% | 66% | 63% | -4.7% | -3.0% |
| Medicaid Day % | 5% | 1% | 1% | +2.9% | -63.8% |
COVID Impact & Recovery
Resilience Score: 50/100 — Stressed — slow recovery from COVID
Revenue recovery from FY2020 to FY2022: +16.2% ($36M → $42M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.8%
This Hospital
+7.6%
State Avg
Latest Margin
-17.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $45M | -21.0% |
| FY2024 (proj) | $48M | -24.1% |
| FY2025 (proj) | $51M | -27.2% |